← Back to Latest
Health Tech

“The goal isn't building a billion dollar company, that will be the result. The goal is saving millions of lives.”

Dr Yogesh Gupta, Founder of Gaston Ai
Dr Yogesh Gupta, Founder of Gaston Ai

Gaston Ai maps biomarkers to personalised food and nutrient recommendations proven to reduce the risk of non-communicable diseases, aiming to reshape how entire populations prevent illness through precision nutrition powered by AI.

The big idea: By combining AI, biomarkers, and precision nutrition, Gaston Ai targets the root cause of the global chronic disease burden: generic dietary guidance applied to biologically unique individuals.

Everything today is generic. Whether it is nutrition advice, or supplements or guidelines. But your biology isn't generic. How food interacts with your metabolism is deeply personal.

— Dr Yogesh Gupta

Context: Research has demonstrated high variability in glycemic responses to identical meals, showing universal dietary guidelines may have limited value.

Source: Zeevi, D. et al. (2015). Personalized nutrition by prediction of glycemic responses. Cell, 163(5), 1079 to 1094. Summarised for clarity.

Why it matters: Tailored nutrition doesn't just extend life. It prevents real, everyday problems.

  1. Chronic diseases like Type 2 Diabetes and cardiovascular disease.
  2. Energy crashes and sleep issues.
  3. Gut problems (IBS, bloating).
  4. Muscle loss with age.
  5. Slow recovery post illness or injury.

Measurable healthcare savings

Gaston Ai's precision nutrition can deliver measurable savings to healthcare systems by targeting the costliest outcomes.

  1. Preventing avoidable hospital admissions.
  2. Keeping chronic patients stable and out of hospital.
  3. Accelerating recovery and reducing bed days.
  4. Delaying onset of high-cost chronic conditions.

"We could save billions that are currently spent treating preventable diseases."

— Yogesh Gupta

Context: Investing in prevention now generates substantial long-term savings and improves quality of life.

Source: McManus E. PharmacoEconomics, Open (2024). Summarised for clarity.

Zoom in: Gaston Ai embeds its AI models directly into the workflows of healthcare providers and insurers, helping partners cut costs and improve outcomes at the point of care.

What's next: The company has secured partnerships in Mexico and India, with more underway in the Middle East. Gaston Ai is now raising £2.5 million to accelerate global expansion. If Gaston Ai interests you, connect with Dr. Yogesh Gupta on LinkedIn.


← Back to Latest